Nerea Zabaleta, PhD, is an Instructor at Harvard Medical School and researcher at the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear Infirmary in Boston, USA, a part of the the Ocular Genomics Institute. She completed the PhD degree in Biomedical Research at the University of Navarra, Spain. Dr. Zabaleta has an ample experience in the gene therapy and vaccine translational research using the adeno-associated viral (AAV) vector. Her goal is to optimize AAV vectors for different applications by designing synthetic vectors that meet the efficacy, specificity and toxicity criteria required for each application. She has published in high impact peer-review journals and is co-inventor in two patents. She is board member of ECUSA (Spanish Scientist in USA, non-profit) and volunteers her time to advocate for inclusion and gender equity.
Nerea Zabaleta, PhD, is an Instructor at Harvard Medical School and researcher at the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear Infirmary in Boston, USA, a part of the the Ocular Genomics Institute. She completed the PhD degree in Biomedical Research at the University of Navarra, Spain. Dr. Zabaleta has an ample experience in the gene therapy and vaccine translational research using the adeno-associated viral (AAV) vector. Her goal is to optimize AAV vectors for different applications by designing synthetic vectors that meet the efficacy, specificity and toxicity criteria required for each application. She has published in high impact peer-review journals and is co-inventor in two patents. She is board member of ECUSA (Spanish Scientist in USA, non-profit) and volunteers her time to advocate for inclusion and gender equity.